文献速递脑血管病认知障碍与痴呆

首次缺血性卒中后静脉溶栓与痴呆发生率降低相关

Intravenous Thrombolysis After First-Ever Ischemic Stroke and Reduced Incident Dementia Rate.
PubMed 文献 · Stroke · 2021-12-30

该观察性研究纳入安大略卒中登记中7072例首次缺血性卒中且既往无痴呆诊断的患者,采用逆概率治疗加权Cox模型分析。溶栓与卒中后1年痴呆发生率相对降低24%相关(原因特异性HR 0.76,95%CI 0.58-0.97),5年时仍显著(HR 0.79,95%CI 0.66-0.91),随访结束时(中位6.3年)亦显著(HR 0.79,95%CI 0.68-0.89)。

要点

  • 首次缺血性卒中后溶栓与1年痴呆发生率相对降低24%相关(HR 0.76)。
  • 该关联在5年(HR 0.79)及随访结束时(中位6.3年,HR 0.79)仍显著。
  • 作者认为评估溶栓风险/获益时应将新发痴呆作为相关结局。

核心结论

  • 首次缺血性卒中后溶栓与痴呆发生率降低独立相关。
  • 作者认为评估缺血性卒中患者溶栓风险/获益时,应将新发痴呆视为相关结局。

研究设计与样本

  • 采用实用性观察设计,纳入安大略卒中登记中既往未诊断痴呆的首次缺血性卒中患者。
  • 共纳入7072例患者,女性3276例(46.3%),平均年龄71.0岁(SD 12.8)。
  • 采用逆概率治疗加权Cox比例风险模型估计溶栓与新发痴呆关联的原因特异性风险比。

主要发现

  • 2003年7月至2013年3月共纳入7072例缺血性卒中患者,38.2%(n=2705)接受溶栓,其中77.2%(n=2087)在卒中发作3小时内给药。
  • 卒中后第1年,溶栓与痴呆发生率相对降低24%相关(原因特异性HR 0.76,95%CI 0.58-0.97)。
  • 该关联在5年时仍显著(原因特异性HR 0.79,95%CI 0.66-0.91),随访结束时(中位6.3年)亦显著(原因特异性HR 0.79,95%CI 0.68-0.89)。

临床怎么用

  • 原文结论指出,评估缺血性卒中患者溶栓风险/获益时,应考虑将新发痴呆作为相关结局。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The use of intravenous thrombolysis is associated with improved clinical outcomes. Whether thrombolysis is associated with reduced incidence of poststroke dementia remains uncertain. We sought to estimate if the use of thrombolysis following first-ever ischemic stroke was associated with a reduced rate of incident dementia using a pragmatic observational design. METHODS: We included first-ever ischemic stroke patients from the Ontario Stroke Registry who had not previously been diagnosed with dementia. The primary outcome was incident dementia ascertained by a validated diagnostic algorithm. We employed inverse probability of treatment-weighted Cox proportional hazard models to estimate the cause-specific hazard ratio for the association of thrombolysis and incident dementia at 1 and 5 years following stroke. RESULTS: From July 2003 to March 2013, 7072 patients with ischemic stroke were included, 3276 (46.3%) were female and mean age was 71.0 (SD, 12.8) years. Overall, 38.2% of the cohort (n=2705) received thrombolysis, 77.2% (n=2087) of which was administered within 3 hours of stroke onset. In the first year following stroke, thrombolysis administration was associated with a 24% relative reduction in the rate of developing dementia (cause-specific hazard ratio, 0.76 [95% CI, 0.58-0.97]). This association remained significant at 5 years (cause-specific hazard ratio, 0.79 [95% CI, 0.66-0.91]) and at the end of follow-up (median 6.3 years; cause-specific hazard ratio, 0.79 [95% CI, 0.68-0.89]). CONCLUSIONS: Thrombolysis administration following first-ever ischemic stroke was independently associated with a reduced rate of dementia. Incident dementia should be considered as a relevant outcome when evaluating risk/benefit of thrombolysis in ischemic stroke patients.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Cerasuolo JO, Mandzia J, Cipriano LE, et al. Intravenous Thrombolysis After First-Ever Ischemic Stroke and Reduced Incident Dementia Rate. Stroke. 2021. PMID: 34965738. doi:10.1161/STROKEAHA.121.034969

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。